Insulin Resistance: What Every Woman Should Know

There is a condition affecting hundreds of millions of people worldwide that most of them have never heard of. It has no dramatic onset, no single defining moment where you suddenly feel ill. It creeps in quietly, over months and years, wearing a dozen different disguises. It masquerades as laziness when it makes you tired. It disguises itself as a lack of willpower when it makes you hungry an hour after eating. It hides behind the label of stress when it clouds your thinking and disrupts your sleep. And by the time most people discover it has a name, it has often already been reshaping their biology for years.

That condition is insulin resistance — and if you are a woman, it is one of the most important things you can understand about your own body.

Insulin resistance sits at the root of some of the most prevalent and consequential health conditions of our time: type 2 diabetes, polycystic ovary syndrome, obesity, cardiovascular disease, non-alcoholic fatty liver disease, and increasingly, certain cancers and cognitive decline. It is not a niche concern for people who are already unwell. It is a metabolic shift that can begin in otherwise healthy-seeming people — including lean women in their twenties and thirties — long before any conventional diagnostic marker raises a flag.

Understanding insulin resistance is not about fear. It is about clarity. It is about having the biological literacy to recognise what your body is doing, why it is doing it, and what you can meaningfully do about it. That is exactly what this article aims to give you.

What Is Insulin, and Why Does It Matter?

To understand insulin resistance, you first need to understand insulin itself — what it is, what it does, and why it is so central to how your body functions.

Insulin is a hormone produced by the beta cells of the pancreas, a gland tucked behind the stomach. Its primary job is to act as a key. When you eat carbohydrates — whether that is a bowl of oatmeal, a piece of fruit, a slice of bread, or a can of soda — your digestive system breaks those carbohydrates down into glucose, the simplest form of sugar. That glucose enters the bloodstream, raising blood glucose levels. The pancreas detects this rise and responds by releasing insulin into the bloodstream.

Insulin then travels to cells throughout the body — in muscle, fat tissue, and the liver — and binds to receptors on their surface, essentially unlocking the cell door to allow glucose to enter. Inside the cell, that glucose is either burned immediately for energy or stored for later use — as glycogen in the muscles and liver, or converted to fat for longer-term storage. Once glucose has been cleared from the bloodstream, blood sugar levels return to baseline, insulin levels fall, and the system resets.

In a healthy metabolic state, this process is elegant, efficient, and largely invisible. You eat, insulin rises, glucose is cleared, insulin falls. The whole thing happens in the background while you get on with your life.

But insulin does not stop at glucose regulation. It is one of the most wide-ranging hormones in the body, with receptors on virtually every cell type. It influences fat storage and fat burning, protein synthesis, inflammation, the production of sex hormones, kidney function, appetite signalling, and even brain activity. This is why, when insulin stops working properly, the effects are felt so broadly and so deeply across so many different systems.

What Is Insulin Resistance?

Insulin resistance occurs when the cells of the body — primarily in the muscles, liver, and fat tissue — stop responding normally to insulin’s signal. The key no longer fits the lock as smoothly as it once did. Glucose cannot enter the cells as efficiently, so it lingers in the bloodstream at higher levels than it should.

The pancreas detects this elevated blood glucose and responds the only way it knows how: by producing more insulin. If a little insulin is not getting the job done, it sends more. In the early stages of insulin resistance, this compensatory strategy works. Blood glucose levels are kept within a broadly normal range — but only because the pancreas is working far harder than it should have to, flooding the system with insulin to force the response that should be happening naturally.

This state — normal or near-normal blood glucose maintained by chronically elevated insulin — is called compensated insulin resistance, and it is where the vast majority of people with insulin resistance sit for years, sometimes decades, without knowing anything is wrong. Standard blood glucose tests come back normal. Doctors see nothing to flag. And all the while, the chronically high insulin is quietly doing damage across multiple body systems.

“Insulin resistance is not a light switch that flips from healthy to diabetic. It is a gradual dimming — a slow deterioration of cellular sensitivity that unfolds over years, shaped by genetics, lifestyle, stress, and hormonal environment.”

Over time, if insulin resistance is not addressed, the pancreatic beta cells begin to struggle under the sustained demand for excess insulin production. Their capacity to keep up gradually declines. Blood glucose levels begin to rise more persistently. First into the prediabetic range, and eventually, if nothing changes, into the diabetic range. Type 2 diabetes, in most cases, is the end point of a long progression that began with insulin resistance years or decades earlier.

But type 2 diabetes is only one of the many conditions that chronic insulin resistance drives. The elevated insulin itself — long before blood glucose becomes an issue — is biologically active and harmful in ways that extend far beyond glucose metabolism.

Why Women Need to Pay Particular Attention

Insulin resistance affects both men and women, but women face a set of unique vulnerabilities and complexities that make it especially important for them to understand.

The PCOS Connection

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, and insulin resistance is central to its pathophysiology in the majority of cases. High insulin levels directly stimulate the ovaries and adrenal glands to produce excess androgens — male-type hormones like testosterone. These elevated androgens disrupt the normal maturation and release of eggs, causing the irregular or absent ovulation that lies at the heart of PCOS-related infertility. They also drive the acne, hirsutism, and hair thinning that characterise the condition.

Critically, insulin resistance in PCOS is present in roughly 70 to 80 percent of affected women regardless of their weight. Lean women with PCOS have insulin resistance just as frequently as heavier women with PCOS — it simply may be less visible and less expected, and therefore even more likely to be missed.

Hormonal Fluctuations Across the Life Cycle

Women’s hormonal environment changes dramatically across the life cycle in ways that directly affect insulin sensitivity. During the luteal phase of the menstrual cycle — the two weeks between ovulation and menstruation — progesterone naturally reduces insulin sensitivity slightly, which is why blood sugar can be harder to manage and carbohydrate cravings more intense in the week before a period. During pregnancy, insulin resistance increases substantially in the second and third trimesters as a normal physiological adaptation to ensure adequate glucose supply to the growing foetus — but in women already predisposed to insulin resistance, this can tip into gestational diabetes.

The menopausal transition brings perhaps the most significant metabolic shift of all. As oestrogen declines, insulin sensitivity deteriorates. The body fat that was previously distributed in the hips and thighs — a relatively metabolically benign pattern — redistributes to the abdomen, where visceral fat is far more metabolically active and inflammatory. Many women who have maintained a stable weight and good metabolic health for decades find their metabolism shifting noticeably during perimenopause, and insulin resistance is a primary driver of that shift.

The Underfasting and Undereating Paradox

Women are disproportionately affected by disordered eating patterns and decades of diet culture that have encouraged chronic undereating, extreme caloric restriction, and the elimination of entire food groups. Paradoxically, severe caloric restriction — particularly when combined with high stress — can worsen insulin resistance by elevating cortisol, depleting muscle mass (muscle is the primary site of insulin-mediated glucose uptake), and dysregulating the appetite hormones leptin and ghrelin. Many women who have spent years restricting their food intake in pursuit of weight loss have inadvertently made their insulin resistance worse, not better.

The Symptoms: What Insulin Resistance Feels Like

This is where the practical value of understanding insulin resistance becomes most immediate. Because insulin resistance is invisible on standard blood tests until it has progressed significantly, symptoms are often the first and most important clue. The challenge is that those symptoms are so common and so varied that they are easily dismissed or attributed to other causes.

Fatigue After Eating

One of the most characteristic patterns of insulin resistance is the post-meal energy crash. You eat a meal — particularly one rich in refined carbohydrates — and within an hour or two you feel a wave of tiredness, mental fog, and sometimes even irritability or shakiness. What is happening physiologically is a blood sugar spike followed by an exaggerated insulin response that drives blood glucose down too fast and too far, leaving you in a relative hypoglycaemic trough. This cycle — spike, crash, hunger, repeat — is the metabolic signature of insulin resistance, and once you know to look for it, it becomes unmistakeable.

Hunger That Returns Quickly After Meals

Insulin resistance disrupts the normal satiety signalling that should tell your brain you have eaten enough and keep you satisfied for three to four hours. Chronically elevated insulin interferes with leptin — the hormone produced by fat cells that signals fullness to the hypothalamus. When leptin signalling is impaired, the brain does not receive the “you are fed” message efficiently, and hunger returns sooner than it should. Many women with insulin resistance describe feeling as though they are never truly satisfied, regardless of how much they have eaten — a deeply frustrating experience that is often misinterpreted as a lack of self-control rather than a genuine hormonal disruption.

Carbohydrate Cravings

The blood sugar rollercoaster of insulin resistance generates intense cravings for carbohydrates, particularly refined sugars and starches. When blood glucose drops after an insulin-driven crash, the brain — which runs almost exclusively on glucose — sends urgent signals for fast fuel. The result is a craving for exactly the foods that perpetuate the cycle: sweet, starchy, quickly digestible carbohydrates. This is not a character flaw. It is biology. Understanding that cravings are driven by a metabolic imbalance rather than personal weakness is both accurate and, for many women, genuinely liberating.

Abdominal Weight Gain

Insulin is a powerful fat-storage hormone. Chronically elevated insulin promotes the deposition of fat, and it does so preferentially in the abdominal region — both the subcutaneous fat just beneath the skin, and the visceral fat that surrounds the internal organs. This is why insulin resistance is so closely associated with the apple-shaped body distribution that carries the highest cardiovascular and metabolic risk. Women who notice that weight is accumulating around their midsection despite no significant change in diet or activity, or who find that abdominal fat is stubbornly resistant to loss even when they are eating well and exercising, should consider insulin resistance as a likely contributing factor.

Skin Tags and Acanthosis Nigricans

Two skin manifestations are so closely associated with insulin resistance that they are considered clinical markers of the condition. Skin tags — small, soft, benign growths of skin that appear on the neck, armpits, groin, or eyelids — are frequently seen in people with insulin resistance and are thought to result from the growth-promoting effects of elevated insulin on skin cells. Acanthosis nigricans is a velvety darkening and thickening of the skin in body folds and creases, particularly the back of the neck, the armpits, and the groin. If you have noticed either of these changes and wondered what caused them, insulin resistance is the most likely answer.

Brain Fog and Poor Concentration

The brain is exquisitely sensitive to blood glucose fluctuations. In insulin resistance, the erratic blood sugar pattern — spiking after carbohydrate-rich meals and crashing in the hours after — translates directly into cognitive symptoms: difficulty concentrating, poor memory, mental haziness, and that peculiar inability to think clearly that people describe as brain fog. There is also growing evidence that insulin resistance in the brain itself — where insulin receptors are abundant and insulin plays important roles in neuronal function — may contribute to cognitive decline and is being investigated as a significant factor in the development of Alzheimer’s disease, sometimes referred to in research contexts as “type 3 diabetes.”

Irregular Periods and Hormonal Symptoms

As discussed, elevated insulin stimulates androgen production in the ovaries, which disrupts the hormonal cascade that drives ovulation. For women with underlying PCOS, insulin resistance is often the primary driver of their cycle irregularity, their acne, their unwanted hair growth, and their fertility challenges. But even women without a PCOS diagnosis can experience cycle disruption driven by insulin resistance — particularly if they are also under significant stress, which adds the amplifying effect of elevated cortisol to the metabolic picture.

High Blood Pressure

Elevated insulin directly affects kidney function, promoting sodium retention and increasing the volume of fluid in the circulatory system. It also increases the activity of the sympathetic nervous system, raising heart rate and constricting blood vessels. The cumulative result is elevated blood pressure — and this is why hypertension is so frequently found alongside insulin resistance as part of the metabolic syndrome cluster.

Elevated Triglycerides and Low HDL Cholesterol

The liver responds to chronically high insulin levels by ramping up the production of triglycerides — a type of fat circulated in the bloodstream. High triglycerides paired with low HDL (the so-called “good” cholesterol) is the lipid signature of insulin resistance, and it is a far more informative cardiovascular risk marker than total cholesterol or LDL alone. If your blood lipid results show this pattern — triglycerides above 1.7 mmol/L and HDL below 1.2 mmol/L in women — insulin resistance is a very likely explanation.

How Is Insulin Resistance Diagnosed?

This is one of the more frustrating aspects of insulin resistance from a patient perspective: it is not routinely tested for in standard medical care, and the tests that are commonly used are poorly suited to detecting it in its early, compensated stages.

Fasting Blood Glucose

A fasting blood glucose test measures the concentration of glucose in your blood after an overnight fast. It is widely used, inexpensive, and easily performed. But it is a late-stage marker. Because the pancreas compensates for insulin resistance by producing more insulin, blood glucose levels can be maintained within the normal range for years — even decades — of insulin resistance. A normal fasting glucose does not rule out insulin resistance; it simply tells you that your pancreas is still compensating adequately.

HbA1c

HbA1c, or glycated haemoglobin, measures the average blood glucose over the previous two to three months. It is useful for monitoring diabetes and identifying prediabetes, but it suffers from the same limitation as fasting glucose: it is a late marker that will not become abnormal until insulin resistance has already progressed substantially.

Fasting Insulin

A fasting insulin test is the most direct and clinically useful early marker of insulin resistance available in routine practice — and yet it is rarely ordered by GPs unless specifically requested. A fasting insulin level above 8 to 10 mIU/L in the context of normal fasting glucose is strongly suggestive of compensated insulin resistance. Levels above 15 to 20 mIU/L in a fasting state represent significant insulin resistance and warrant urgent lifestyle intervention.

HOMA-IR

The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) is calculated from fasting glucose and fasting insulin together, and provides a more nuanced picture than either measurement alone. A HOMA-IR score above 1.9 is generally considered to indicate early insulin resistance; above 2.9 suggests significant insulin resistance. Ask your doctor to calculate this if you have had both fasting glucose and fasting insulin measured.

The Oral Glucose Tolerance Test (OGTT) with Insulin

The most sensitive diagnostic tool available is an oral glucose tolerance test that measures not just glucose but also insulin at multiple time points — fasting, 30 minutes, 60 minutes, and 120 minutes after consuming a standardised glucose drink. This test can reveal patterns of insulin resistance and compensatory hyperinsulinaemia that are invisible on fasting measurements alone. It is unfortunately not routinely offered, but it is worth requesting if you have strong clinical suspicion of insulin resistance and normal fasting markers.

What Causes Insulin Resistance?

Insulin resistance is not caused by any single factor. It is the product of an interaction between genetic predisposition and environmental and lifestyle factors — and understanding the causes is essential for understanding how to address it.

Excess Body Fat, Particularly Visceral Fat

Visceral fat — the fat stored deep in the abdominal cavity around the organs — is metabolically distinct from subcutaneous fat. It is far more actively involved in releasing inflammatory signalling molecules called cytokines, which directly interfere with insulin signalling at the cellular level. This is why abdominal obesity is so much more strongly associated with metabolic disease than fat distributed elsewhere in the body. It is also why waist circumference — a proxy measure for visceral adiposity — is a better predictor of insulin resistance risk than BMI.

Physical Inactivity

Muscle tissue is the largest site of insulin-mediated glucose uptake in the body. When you contract a muscle, it can take up glucose independently of insulin — which is one of the reasons exercise is so powerfully beneficial for insulin sensitivity. A sedentary lifestyle, conversely, means less muscle mass, less non-insulin-dependent glucose uptake, and a greater burden on the insulin signalling system. Even independent of body weight, physical inactivity is a significant driver of insulin resistance.

Diet High in Refined Carbohydrates and Ultra-Processed Foods

A diet chronically high in rapidly digested carbohydrates — white bread, white rice, sugary drinks, confectionery, highly processed snack foods — repeatedly drives large insulin spikes, keeping circulating insulin persistently elevated and gradually desensitising cells to its signal. Ultra-processed foods compound this by displacing nutrient-dense whole foods that support metabolic health and contain fibre that slows glucose absorption.

Chronic Stress and Elevated Cortisol

Cortisol, the primary stress hormone, is physiologically opposed to insulin. It raises blood glucose — an evolutionary adaptation designed to provide quick energy during a threat — which in turn demands more insulin production. Under chronic stress, this dynamic is sustained rather than temporary, contributing to persistently elevated glucose and insulin levels. Cortisol also promotes visceral fat deposition, further worsening the metabolic picture. Women under sustained psychological, occupational, or relational stress are therefore at meaningfully elevated insulin resistance risk, independent of their diet and activity levels.

Poor Sleep

The relationship between sleep and insulin sensitivity is direct, measurable, and underappreciated. Even a single night of significantly disrupted sleep measurably impairs insulin sensitivity the following day. Chronic poor sleep — whether from insomnia, sleep apnoea, shift work, or the night sweats of perimenopause — creates a sustained metabolic burden. Sleep deprivation elevates cortisol and ghrelin (the hunger hormone), suppresses leptin (the fullness hormone), and impairs the cellular insulin signalling pathways, all simultaneously.

Gut Microbiome Disruption

The gut microbiome — the vast community of bacteria inhabiting the digestive tract — plays a significant role in metabolic regulation. Research over the past decade has established clear associations between specific patterns of microbiome composition and insulin resistance. A microbiome with reduced diversity, depleted beneficial species, and an overgrowth of certain pro-inflammatory bacteria produces metabolites that impair insulin signalling and promote systemic inflammation. Antibiotic use, ultra-processed diets, chronic stress, and insufficient dietary fibre all negatively affect the microbiome in ways that may contribute to insulin resistance.

Genetic Predisposition

Genetics establish the baseline at which insulin resistance risk begins. Some ethnic groups — including South Asian, Middle Eastern, Hispanic, and East Asian populations — have significantly higher genetic susceptibility to insulin resistance and develop its metabolic consequences at lower body weights than people of Northern European ancestry. This means that the conventional weight-based risk thresholds used in clinical practice may substantially underestimate risk in these populations. If you have a family history of type 2 diabetes, PCOS, or cardiovascular disease, your baseline insulin resistance risk is elevated and warrants proactive monitoring.

Endocrine Disruptors

A growing body of evidence implicates environmental chemicals — particularly those that interfere with hormonal signalling, known as endocrine-disrupting chemicals — in the development of insulin resistance. Bisphenol A (BPA) and phthalates from plastics, certain pesticide residues on food, and persistent organic pollutants have all been shown to impair insulin sensitivity in laboratory and epidemiological studies. Women have disproportionate exposure to many of these chemicals through personal care products, food packaging, and household items.

The Downstream Consequences: Why Insulin Resistance Matters So Much

If insulin resistance remained simply a matter of slightly elevated blood sugar and a tendency to gain weight around the middle, it would be serious enough. But its reach extends far beyond these visible manifestations, touching virtually every major chronic disease of modern life.

Type 2 Diabetes

The most direct consequence. As insulin resistance progresses and the pancreatic beta cells exhaust their capacity to compensate, blood glucose rises into the prediabetic and then the diabetic range. Type 2 diabetes is not an inevitable outcome of insulin resistance — it is a preventable progression — but it requires early identification and meaningful intervention to prevent.

Cardiovascular Disease

Insulin resistance drives cardiovascular risk through multiple simultaneous mechanisms: elevated blood pressure, the atherogenic lipid pattern of high triglycerides and low HDL, systemic inflammation, endothelial dysfunction (damage to the inner lining of blood vessels), and pro-thrombotic changes that increase clotting tendency. Women are particularly poorly served by conventional cardiovascular risk assessment, which has historically been based on male populations and tends to underestimate risk in women — particularly the risk attributable to metabolic factors like insulin resistance.

Non-Alcoholic Fatty Liver Disease (NAFLD)

When the liver is repeatedly exposed to excess glucose and insulin, it converts the surplus into fat and stores it within its own cells — a condition called non-alcoholic fatty liver disease. NAFLD affects roughly a quarter of the global population and is now the most common liver condition in the developed world. In most cases it is driven by insulin resistance, and in many cases it is entirely silent — producing no symptoms until it has progressed to the inflammatory stage (non-alcoholic steatohepatitis, or NASH), which can eventually lead to cirrhosis and liver failure.

Polycystic Ovary Syndrome

As explored above, insulin resistance is the central metabolic driver of PCOS in the majority of women with the condition, fuelling elevated androgens, anovulation, cycle irregularity, and the full spectrum of its symptoms. Addressing insulin resistance is therefore not just one part of PCOS management — it is the most fundamental intervention available.

Certain Cancers

Elevated insulin has growth-promoting properties — insulin receptors are present on many cancer cell types, and insulin stimulates cellular proliferation. Chronically elevated insulin is associated with increased risk of several cancers, most notably endometrial cancer, breast cancer, colorectal cancer, and pancreatic cancer. The endometrial cancer risk is particularly relevant for women with PCOS, who are already at elevated risk through the mechanism of unopposed oestrogen exposure.

Cognitive Decline and Dementia

The brain is now understood to be an insulin-sensitive organ. Insulin receptors are abundant in the hippocampus and other brain regions critical for memory and cognition. Insulin resistance in the brain impairs the clearance of amyloid beta — the protein that accumulates in Alzheimer’s disease plaques — and disrupts neuronal energy metabolism. Midlife insulin resistance is increasingly recognised as a significant modifiable risk factor for late-life dementia, which makes addressing it in your thirties, forties, and fifties potentially one of the most important investments you can make in your long-term cognitive health.

Reversing Insulin Resistance: What the Evidence Actually Shows

Here is the genuinely good news: insulin resistance, particularly in its early and moderate stages, is one of the most responsive conditions to lifestyle intervention of any chronic metabolic disorder. The cellular mechanisms of insulin resistance are not fixed. They can be meaningfully improved — often dramatically — through targeted changes in how you eat, move, sleep, and manage stress.

Dietary Approaches

No single dietary pattern has a monopoly on improving insulin sensitivity, but several principles are consistently supported by the evidence. Reducing the overall glycaemic load of the diet — meaning the total quantity and speed of carbohydrate digestion across the day — is foundational. This means prioritising whole, minimally processed carbohydrates over refined ones, pairing carbohydrates with protein, fat, and fibre to slow their digestion and blunt the insulin response, and being mindful of portion sizes of even “healthy” carbohydrate sources like grains and root vegetables when insulin resistance is significant.

Adequate dietary protein is particularly important and often underprioritised, especially by women. Protein has a minimal direct effect on blood glucose and insulin, supports the preservation and growth of muscle mass (critical for insulin sensitivity), and significantly improves satiety — reducing the carbohydrate cravings that are so characteristic of insulin resistance. Aiming for a minimum of 1.2 to 1.6 grams of protein per kilogram of body weight per day is a reasonable evidence-based target for women working to improve insulin sensitivity.

Healthy fats — from olive oil, avocado, nuts, seeds, and fatty fish — do not drive insulin secretion and provide sustained energy that helps break the blood sugar spike-and-crash cycle. Mediterranean and low-carbohydrate dietary patterns have both shown strong efficacy in improving insulin sensitivity in clinical trials, though individual responses vary and the most effective approach is ultimately the one that is sustainable for the individual.

Exercise: The Most Powerful Single Intervention

Physical activity is arguably the most potent single tool available for improving insulin sensitivity — and its effects are both immediate and cumulative. A single bout of moderate-intensity exercise improves insulin sensitivity for 24 to 72 hours afterward by depleting muscle glycogen stores, which creates a metabolic demand for glucose uptake that is largely independent of insulin. Over time, regular exercise increases muscle mass, mitochondrial density, and the number of glucose transporter proteins (GLUT4) in muscle cells, producing durable improvements in insulin sensitivity.

Resistance training deserves particular emphasis because it is consistently underutilised by women, often in favour of exclusively cardiovascular exercise. Building and maintaining muscle mass is one of the most important long-term metabolic investments a woman can make, and resistance training — whether with weights, resistance bands, or bodyweight — is the primary tool for doing so. The combination of resistance training and aerobic exercise appears to be more effective than either alone for improving insulin sensitivity.

Even small amounts of movement matter. Breaking up prolonged sitting with short walks — even five minutes every hour — has been shown to meaningfully reduce post-meal blood glucose spikes. For women whose schedules make formal exercise challenging, this kind of incidental movement can be a practical and effective starting point.

Sleep Optimisation

Improving sleep quality and duration is a metabolic intervention, not just a wellbeing one. Prioritising seven to nine hours of sleep, addressing sleep apnoea if present, managing the night sweats and sleep disruption of perimenopause, and maintaining consistent sleep and wake times to support circadian rhythm — all of these have demonstrable effects on insulin sensitivity. For women in the perimenopausal transition whose sleep is significantly disrupted by hormonal fluctuations, addressing the hormonal root cause through appropriate medical support may be a prerequisite for meaningful metabolic improvement.

Stress Management

Given the direct metabolic impact of cortisol on insulin sensitivity, stress management is not a soft add-on to a metabolic health strategy — it is a core component. The evidence base for mindfulness-based stress reduction, yoga, and other relaxation practices on cortisol levels and insulin sensitivity is growing and increasingly robust. For women under significant chronic stress, no amount of dietary optimisation will fully compensate for the ongoing cortisol-driven insulin resistance until the stress load is meaningfully addressed.

Targeted Supplements

Several supplements have a meaningful evidence base for supporting insulin sensitivity, though they are best considered adjuncts to the lifestyle measures above rather than substitutes for them. Magnesium deficiency is common in insulin resistance, and magnesium plays a direct role in over 300 enzymatic processes including glucose metabolism; supplementation in deficient individuals has been shown to improve insulin sensitivity. Berberine, a plant-derived compound, has demonstrated insulin-sensitising effects in clinical trials comparable in some studies to metformin. Myo-inositol, particularly at a 40:1 ratio with D-chiro-inositol, has strong evidence specifically in the context of PCOS and insulin resistance. Always discuss supplementation with a healthcare provider, particularly if you are taking other medications, as interactions are possible.

Medication

For women in whom lifestyle intervention alone is insufficient, or where insulin resistance has progressed significantly, pharmaceutical options are available and effective. Metformin — an insulin sensitiser widely used in type 2 diabetes — is also prescribed off-label for PCOS and prediabetes, and has a well-established safety record over decades of use. GLP-1 receptor agonists, including semaglutide (known commercially as Ozempic and Wegovy), have demonstrated remarkable efficacy in improving insulin sensitivity, reducing visceral fat, and restoring menstrual regularity in women with PCOS and obesity, and are increasingly moving from specialist to mainstream clinical use. Medication decisions should always be made in partnership with a knowledgeable clinician.

Monitoring Your Progress

One of the most empowering aspects of addressing insulin resistance is that its improvement is measurable. You do not have to guess whether your interventions are working. Key markers to track in conversation with your doctor include fasting insulin (the most sensitive early marker), HOMA-IR, fasting glucose, HbA1c, triglycerides, HDL cholesterol, and waist circumference. Regular monitoring — every three to six months when actively working to improve metabolic health — provides both objective feedback on progress and the motivational reinforcement of seeing the numbers move in the right direction.

Subjective markers matter too. The post-meal energy crash becoming less severe. The carbohydrate cravings quietening. The brain fog lifting. Sleep improving. The abdominal bloating reducing. These experiential changes often precede measurable laboratory improvements and are important signals that your biology is responding.

The Bigger Picture: Metabolic Health as a Foundation

Insulin resistance sits at the convergence point of so many of the health challenges that women face — from PCOS and infertility in the reproductive years, to weight gain and cardiovascular risk in midlife, to cognitive decline in later life. Understanding it is not about adding another health anxiety to an already long list. It is about seeing the thread that connects many seemingly separate concerns and recognising that addressing it at the root has upstream benefits across multiple body systems simultaneously.

A woman who improves her insulin sensitivity through targeted lifestyle changes is not just reducing her diabetes risk. She is simultaneously improving her hormonal balance, supporting her fertility, protecting her cardiovascular health, reducing her cancer risk, sharpening her cognition, stabilising her mood, and building a metabolic foundation that will serve her through every decade of her life.

That is not a small thing. That is, arguably, one of the most important investments in long-term health that any woman can make.

And it begins with understanding what insulin resistance is, recognising whether it might be affecting you, and knowing that the power to change it sits, to a significant and meaningful degree, in your hands.